109 related articles for article (PubMed ID: 8558913)
21. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
[TBL] [Abstract][Full Text] [Related]
22. Evidence that human haematopoietic stem cells (HSC) do not reside within the CD34+KIT- cell population.
Ratajczak J; Machalinski B; Majka M; Kijowski J; Marlicz W; Rozmyslowicz T; Ostrowski M; Ratajczak MZ
Ann Transplant; 1999; 4(1):22-30. PubMed ID: 10850597
[TBL] [Abstract][Full Text] [Related]
23. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
24. c-Kit receptor (CD117) expression on myeloblasts and white blood cell counts in acute myeloid leukemia.
Woźniak J; Kopeć-Szlezak J
Cytometry B Clin Cytom; 2004 Mar; 58(1):9-16. PubMed ID: 14994370
[TBL] [Abstract][Full Text] [Related]
25. Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts.
Stacchini A; Fubini L; Severino A; Sanavio F; Aglietta M; Piacibello W
Leukemia; 1996 Oct; 10(10):1584-91. PubMed ID: 8847893
[TBL] [Abstract][Full Text] [Related]
26. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
27. Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells.
Dehmel U; Zaborski M; Meierhoff G; Rosnet O; Birnbaum D; Ludwig WD; Quentmeier H; Drexler HG
Leukemia; 1996 Feb; 10(2):261-70. PubMed ID: 8637235
[TBL] [Abstract][Full Text] [Related]
28. Expression of megakaryocytic and erythroid properties in human leukemic cells.
Tani T; Ylänne J; Virtanen I
Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
[TBL] [Abstract][Full Text] [Related]
29. Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells.
Scappini B; Onida F; Kantarjian HM; Dong L; Verstovsek S; Keating MJ; Beran M
Clin Cancer Res; 2001 Dec; 7(12):3884-93. PubMed ID: 11751479
[TBL] [Abstract][Full Text] [Related]
30. Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells.
Jardí M; Inglés-Esteve J; Burgal M; Azqueta C; Velasco F; López-Pedrera C; Miles LA; Félez J
Thromb Haemost; 1996 Dec; 76(6):1009-19. PubMed ID: 8972026
[TBL] [Abstract][Full Text] [Related]
31. Phenotypes of blasts in acute erythroblastic and megakaryoblastic leukemia--review.
Breton-Gorius J
Keio J Med; 1987 Jan; 36(1):23-45. PubMed ID: 3302500
[No Abstract] [Full Text] [Related]
32. Importance of CD117 in the evaluation of acute leukemias by flow cytometry.
Newell JO; Cessna MH; Greenwood J; Hartung L; Bahler DW
Cytometry B Clin Cytom; 2003 Mar; 52(1):40-3. PubMed ID: 12599181
[TBL] [Abstract][Full Text] [Related]
33. JAS-R, a new megakaryo-erythroid leukemic cell line that secretes erythropoietin.
Sekikawa T; Iwase S; Saito S; Arakawa Y; Agawa M; Horiguchi-Yamada J; Yamada H
Anticancer Res; 2006; 26(2A):843-50. PubMed ID: 16619478
[TBL] [Abstract][Full Text] [Related]
34. Distribution of a hematopoietic-specific differentiation antigen of K562 cells in the human myeloid and lymphoid cell lineages.
Clarke BJ; Liao SK; Leeds C; Soamboonsrup P; Neame PB
Cancer Res; 1987 Aug; 47(16):4254-9. PubMed ID: 3475169
[TBL] [Abstract][Full Text] [Related]
35. Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells.
Kobune M; Takimoto R; Murase K; Iyama S; Sato T; Kikuchi S; Kawano Y; Miyanishi K; Sato Y; Niitsu Y; Kato J
Cancer Sci; 2009 May; 100(5):948-55. PubMed ID: 19245435
[TBL] [Abstract][Full Text] [Related]
36. Primary acute myeloid leukemia cells negative for c-kit receptor protein expression do not proliferate in vitro in response to colony-stimulating factors.
Hirakawa K; Kimura S; Chikayama S; Misawa S; Maekawa T
Leukemia; 1996 Feb; 10(2):279-87. PubMed ID: 8637237
[TBL] [Abstract][Full Text] [Related]
37. Paracrine and autocrine growth mechanisms of human stem cell factor (c-kit ligand) in myeloid leukemia.
Pietsch T
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):285-6. PubMed ID: 7687773
[TBL] [Abstract][Full Text] [Related]
38. A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity.
Mori T; Sugita K; Suzuki T; Okazaki T; Manabe A; Hosoya R; Mizutani S; Kinoshita A; Nakazawa S
Leukemia; 1995 Jul; 9(7):1233-9. PubMed ID: 7543176
[TBL] [Abstract][Full Text] [Related]
39. Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells.
Chinen H; Matsuoka K; Sato T; Kamada N; Okamoto S; Hisamatsu T; Kobayashi T; Hasegawa H; Sugita A; Kinjo F; Fujita J; Hibi T
Gastroenterology; 2007 Aug; 133(2):559-73. PubMed ID: 17681176
[TBL] [Abstract][Full Text] [Related]
40. [Study of thrombopoietin and its receptor C-mpl in acute leukemia].
Guo Y; Bian S; Luo M
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):120-3. PubMed ID: 11601235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
